Silvestro Stephen L 4
4 · OptimizeRx Corp · Filed May 19, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Silvestro Stephen L
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-05-15+46,948→ 168,262 total - Award
Stock Option
2025-05-15+80,884→ 80,884 totalExercise: $10.65From: 2026-05-15Exp: 2029-05-15→ Common Stock (80,884 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.